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Abstract 
Osteoarthritis (OA) is a rheumatological disorder accompanied with imbalance 
between anabolic and catabolic mediators that lead to the destruction of 
homeostasis of articular cartilage. Currently, Steroids and non-steroidal anti-
inflammatory drugs are commonly used in the management of OA. Besides the 
various side effects of these drugs, they can just moderately alleviate symptoms 
of OA. Hence, to achieve safe and efficacious drugs, the research tendency 
toward exploration of novel sources has been grown up. Various previous 
researches have focused on the use of medicinal plants in the treatment of OA. 
This review focuses on the most efficacious medicinal plants and drugs 
considering related laboratory and clinical evidences. More investigations are 
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Introduction 
Osteoarthritis (OA) is a rheumatological 
disorder accompanied by breakdown of joint cartilage 
and underlying bone (1). It is the most common 
degenerative joint disorder that can affect various 
joints including small (e.g hand) and large (e.g knee) 
joints (2). OA is one of the major causes of pain, 
disability and limited function affecting the elderly (3, 
4). Pain is especially important because it leads to 
decreased productivity and impaired quality of life (5). 
Prevalence of OA is strongly age-dependent with most 
people older than 65 and roughly 80% of those aged 
over 75 showing various degrees of OA in radiographic 
imaging. The disease is not common in people younger 
than 40 (6). Other than age, there are different 
predisposing factors for OA including genetic factors, 
endocrine disorders, joint infection, anatomical and 
orthopedic disorders (i.e. congenital hip dislocation), 
muscle weakness, trauma, and previous rheumatoid 
arthritis (RA). Obesity can increase the mechanical 
pressure on joints and is a major factor in the 
progression of OA (7, 8). Symptoms of OA include 
pain, swelling, warmth and stiffness. The severity of 
these symptoms depends on the location of affected 
joints and severity of the disease. Any synovial joint 
can be affected by OA but the disease commonly 
affects large load-bearing joints such as knee and hip. 
Breakdown of articular cartilage is the most prominent 
anatomical feature of this disease (9). Inflammation of 
the synovium occurs in early and late stages of OA and 
is thought to be a key component of the disease having 
a significant role in the destruction of cartilage matrix 
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and subsequent exacerbation of symptoms (10, 11). 
There is ample evidence pointing to the role of pro-
inflammatory cytokines especially interleukin-1b (IL-
1b) and tumor necrosis factor-α (TNF-α) in the 
inflammatory process seen in OA (12). These pro-
inflammatory cytokines can increase the level of nitric 
oxide (NO) and prostaglandin E2 (PGE2), leading to 
the increased amount of proteolytic enzymes and 
subsequent cartilage breakdown (13, 14). Activation of 
proteolytic enzymes such as matrix metalloproteinase 
(MMP) promotes degradation of the cartilage causing 
synovitis and creates a vicious cycle leading to more 
joint damage (13, 15, 16). As mentioned before, pain 
is a major cause of decreased quality of life in patients 
with OA, therefore pain killers and anti-inflammatory 
drugs including acetaminophen, nonsteroidal anti-
inflammatory drugs (NSAIDs) and opioid drugs are 
widely used to alleviate OA symptoms (5, 17, 18). 
These drugs have many side effects; for example, 
acetaminophen can cause liver toxicity (19) and 
NSAIDs are associated with gastrointestinal (GI) side 
effects including GI ulcers and bleeding (20). Both 
conventional NSAIDs and COX-2 inhibitors can 
increase cardiovascular risk (21). Some studies show 
NSAIDs can also increase blood pressure (22). 
Severity and prevalence of NSAID-related 
gastrointestinal side effects increase with aging, 
limiting its use in old patients (23). Opioid drugs are 
believed to increase the risk of cardiovascular 
accidents and overall mortality. Compared with 
NSAIDs, opioid drugs are accompanied by a higher 
risk of bone fractures (24, 25); thus, it can be seen that 
conventional OA treatments such as NSAIDs have 
many side effects limiting their use especially in older 
patients. 
Complementary or alternative medicine (CAM) 
is defined as “diagnosis, treatment and/or prevention 
which complements mainstream medicine by 
contributing to a common whole, by satisfying a 
demand not met by orthodoxy or by diversifying the 
conceptual frameworks of medicine”(26). CAM has 
many types, acupuncture (27) and Pulsed 
electromagnetic field (28) are two examples of CAM. 
Herbal medicines are also considered a group of CAM. 
Popular and often self-prescribed,herbal medicines are 
used in a wide range of conditions. Conventional OA 
treatments, as mentioned before, can cause various and 
sometimes life-threatening side effects. Moreover, 
these treatments are not always optimally effective. 
Herbal medicines are usually considered food 
supplements thus are widely available (29). Compared 
to NSAIDs and corticosteroids, the side effects of such 
plants are low; hence, these plants can make a 
substantial contribution to the patients with 
osteoarthritis. In this review, we will focus on recent 
updates on herbal medicines as an alternative treatment 
option for OA. Herbal plants/drugs with both clinical 
and labarotory evidence of effectiveness in 
osteoarthritis are summarized in Table 1. 
Curcuma longa 
Curcuma longa is a plant that naturally grows in 
India and southeast Asia. Curcumin is a metabolite of 
C. longa that has considerable anti-inflammatory 
effects and is thought to be responsible for anti-
inflammatory effects of C. longa (30). In traditional 
Chinese medicine, curcumin has been used for its anti-
inflammatory effects (31). From molecular 
prespective, curcumin can deacreas the level of pro-
inflammatory mediators such as IL-6, IL-8, NO, PGE2, 
and TNF-α. In addition, it has an inhibitory effect on 
NF-κB activation pathway (an important pathway 
causing inflammation) (32-35). Furthermore, 
curcumin can protect joint cartilage by inhibiting the 
production of MMPs and thus preventing cartilage 
breakdown (36, 37). Moreover, it can also increase the 
production of glycosaminoglycan and type 2 collagen 
that are two important structural elements in joint 
cartilage, and can also decrease the apoptosis rate of 
chondrocytes (36, 38). C. longa has been used as an 
adjuvant therapy for OA and has been shown to have 
potentially beneficial effects for treatment of OA (39-
41). These in vitro and in vivo results show promising 
anti-OA effects for C. longa  
Zingiber officinale 
Zingiber officinale commonly known as ginger, 
is a plant that is native to southern Asia and India. 
Ginger has an anti-inflammatory effect through 
reducing prostaglandin and leukotriene production by 
inhibiting 5-lipoxygenase. It can also reduce levels of 
IL-8, IL-1 and TNF-α (42, 43). In some studies ginger 
reduced the levels of NO and PGE2 and their 
subsequent inflammatory effects (44, 45). Ginger can  
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Potential active constituents 
in osteoarthritis 
Supporting studies 
In vitor/ In vivo Clinical 
Curcuma longa Zingibaraceae Curcumin 
Mathy-Hartert et al 
(32), Csaki et al (33), 
Yeh et al (37) 
Kuptniratsaikul et al 
(40), Pinsornsak et al 




Zingibaraceae Curcumin, capsaicin 
Verma et al (43), Jung 
et al (45), Lantz et al 
(46),  
 Altman et al (49), 
Bartels et al (50),  
Harpagophytum 
procumbens 
Sesame Harpagoside Gyurkovska et al (52)  Brien et al (56) 
Rosa canina Rosaceae Galactolipid 
Willich et al (58), 
Daels-Rakotoarison et 
al (60), Orhan et al (61) 
Marstrand et al (63), 
Winther et al (65), 
Petcharat et al (66). 
Rosmarinus 
officinalis 
Lamiaceae Phenolic acids 
Nogueira de Melo et al 
(70), Amaral et al (71) 
Lukaczer et al (72) 
Capsaicin Capsicum Capsaicinoid 
Spiller et al (79), Kim 
et al (80) 
Kosuwon et al (81), 
Mason et al (82), 
Laslettet et al (83) 
Urtica dioica 
Urticaceae 
Flavonoid Riehemann et al (84) 
Randall et al (86), 
Jacquet et al (87) 
SKI 306X Herbal drug 
Comprised of Clematis 
mandshurica, Prunella vulgaris 
and Trichosanthes kirilowii 
Choi et al (73) Jung et al (74) 
Phytodolor 
Herbal drug Comprised of Solidago 
virgaurea ,Populus tremula and 
Fraxinus excelsior 





Comprised of Avocado and 
soybean  
Au et al (88), Ownby et 
al (89), Altinel et al 
(91) 
Appelboom et al (93). 
Maheu et al (94). 
Christensen et al (95). 
reduce the activity of cyclooxygenase-2 (COX2) enzyme. COX2 is an enzyme responsible for the 
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production of many inflammatory mediators including 
prostaglandins thus by inhibiting this enzyme, like the 
drug celecoxib, ginger can decrease the level of 
inflammation (46). Ginger has a positive effect on pain 
control that is comparable to Diclofenac 100 mg in 
patients with OA plus it has no life-threatening side 
effects (47). Ginger extract has been compared to 
Ibuprofen and Indomethacin in patients with OA in 
previous studies. The results have shown Ibuprofen, 
Indomethacin, and ginger extract equally improve the 
pain score (48, 49). Ginger was shown to be superior 
to placebo in terms of reducing pain and disability 
among OA patients and with no serious side effects, it 
has been suggested as a complementary treatment for 
OA (50). 
Harpagophytum procumbens 
Harpagophytum procumbens also known as 
devil's claw is a plant native to southern parts of Africa. 
Harpagoside is one of the main chemical compounds 
of devil's claw and is responsible for a significant 
portion of medical and anti-inflammatory effects of 
this plant (51). The medical effects of this plant are 
from an extract obtained from its roots. Devil’s claw's 
Root's extract is thought to be able to decrease the 
production of inflammatory cytokines (i.e. TNF- ,IL-
1𝛽 and IL-6) PGE2 and NO. Moreover, it can prevent 
arachidonic acid from being metabolized to 
prostaglandins and thromboxanes (prostaglandins and 
thromboxanes are molecules with inflammatory 
effects) thus reducing the inflammation (52-54). 
Devil's claw has shown "encouraging" potential to 
reduce the pain of OA and daily usage of 60 mg 
harpagoside showed "moderately strong evidence" for 
being effective in the treatment of knee, hip and spine 
OA (55). Some RCTs and review articles also show the 
effectiveness of devil's claw as an anti-inflammatory 
and potential treatment for OA (54, 56). There are 
several contraindications for using devil's claw. 
Patients with gastric and duodenal ulcers, gallstone and 
cardiac disease are advised not to use this plant or its 
extracts (56).  
Rosa canina 
Being native to western Asia and Europe, Rosa 
canina is a wild rose species that has shown potential 
to be an adjuvant therapeutic choice for treating OA. 
Rose hip (rose hip is an accessory fruit of this plant) 
has been able to reduce the levels of ESR and CRP, two 
important inflammatory markers, in patients with OA 
and rheumatoid arthritis (57, 58). Studies have shown 
that R.canina extracts reduce the activity of COX-1 and 
COX-2 enzymes and are able to act like a reactive 
oxygen scavenger (reactive oxygen scavengers reduce 
the levels of reactive oxygen species (ROS) and 
oxidative stress) (59, 60). Moreover, rose hip has been 
able to reduce the chemotaxis of polymorphonuclear 
leucocytes and monocytes (61). Galactolipid is an 
active component of rosehip powder which its 
inhibitory potential has been confirmed by laboratory 
and in vitro studies (62). Some studies have shown that 
R.canina extract was able to reduce OA symptoms 
such as pain and stiffness in OA patients (63). In two 
double-blind, randomized, placebo-controlled clinical 
trials, rose hip powder ameliorated OA symptoms, pain 
being one of them, and reduced the usage of 
conventional analgesic drugs (64, 65). In another study 
rose hip powder was able to improve symptoms of 
knee OA after 3 weeks of treatment (66). 
Rosmarinus officinalis 
Rosmarinus officinalis commonly known as 
rosemary is an herb native to the Mediterranean region. 
Phenolic acids have substantial role in anti-
inflammatory and antioxidant capacity of rosemary 
(67, 68). Inhibition of C3b attachment in complement 
system by rosemary can decrease the activation of 
complement system and reduce the subsequent 
inflammatory response caused by activation of this 
system (69). Rosemary can also inhibit the migration 
of leukocytes and thus reduce the inflammation (70). 
Infiltration of tissues by neutrophils is an important 
cause of inflammation as neutrophils can release a 
wide range of inflammatory mediators and harm 
tissues. Rosemary can inhibit tissue neutrophilic 
infiltration it also decreases the level of inflammatory 
cytokines such as IL-1 and TNF-𝛼 (71). In an open-
label trial, the effects of rosemary extract were 
investigated in patients with OA, RA and fibromyalgia. 
Level of hs-CRP was significantly decreased in these 
patients during 4 weeks of treatment. also, a reduction 
in inflammation and improvement of pain score were 
observed during the treatment but remission has not 
occurred in fibromyalgia scores (72). More studies are 
needed to confirm the positive effects of rosemary on 
OA patients. 
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SKI 306X (Clematis mandshurica, Prunella vulgaris, 
and Trichosanthes kirilowii) 
SKI 306X is an herbal drug made of Clematis 
mandshurica, Prunella vulgaris, and Trichosanthes 
kirilowii. It can protect cartilage proteoglycan from 
being destroyed by inflammation. As mentioned 
before, IL-1 is an inflammatory cytokine that rises in 
patients with OA. This cytokine can mediate a 
sequence of reactions that lead to degradation of joint 
proteoglycan. SKI 306X can protect cartilage 
proteoglycan from being destroyed by IL-1 mediated 
reactions and its effects were comparable to the effects 
of diclofenac. When used in animal models of OA, SKI 
306X decreased the infiltration of leucocytes and 
subsequent inflammation of synovial tissue and joint 
(73). When used in patients with OA, SKI 306X 
showed superior effects to placebo for controlling OA 
symptoms such as pain. Additionally, it had similar 
analgesic effects with daily usage of diclofenac 300 
mg.this herbal medicine was well tolerated by patients 
and no adverse effects were observed (55, 74). 
Phytodolor (Solidago virgaurea, Populus tremula, 
and Fraxinus excelsior) 
Phytodolor is an herbal medicine comprised of 
three herbal plants: Solidago virgaurea, Populus 
tremula, and Fraxinus excelsior. Two systemic 
reviews evaluated the efficacy of phytodolor for 
treating OA. These reviews suggest pain and swelling 
reduction, increased joint range of motion and a 
reduction in consumption of NSAIDs in patients 
receiving Phytodolor compared to those receiving 
placebo (75, 76). Also in a review of 6 primary studies, 
positive effects were observed from phytodolor on 
arthritis pain (29). 
Capsaicin (chili pepper) 
Capsaicin is an extract of chili pepper with 
analgesic effects. It reduces pain by selectively 
modulating peripheral sensory nervous system. 
Capsaicin depletes substance p,a neurotransmitter 
responsible for pain sensation from sensory nerve 
terminals. When first applied to the skin, capsaicin 
creates a sensation of irritation and burning. These 
effects are thought to be caused by selective excitation 
of sensory c fibers. In response to this excitation, c 
fibers release neuropeptides, thus after repeated use of 
the capsaicin, these neuropeptides are depleted from c 
fibers. This process causes the long-lasting analgesic 
effect seen with the usage of capsaicin (77, 78). 
Moreover, capsaicin has anti-inflammatory effects. It 
decreases the levels of PGE2, TNF-α and IL-1b and 
inhibits the migration of neutrophils. Additionally, it 
reduces the activity of COX2 enzyme and significantly 
reduces the release of NO, all of these effects cause a 
reduction of inflammation (79, 80). Capsaicin can have 
positive effects on patients with OA. In a cross-over, 
double-blinded, randomized, controlled trial of 100 
patients with mild to moderate knee OA, patients 
treated with 0.0125% capsaicin gel showed statistically 
significant improvement in pain, stiffnes and joint 
movement compared to those treated with placebo 
(81). In a systemic review of six double-blinded, 
randomized, controlled trials, capsaicin was found to 
be a "useful adjuvant therapy" in many patients (82). 
In a study on patients with moderate pain and clinical 
or radiologically defined OA, 
topical capsaicin treatment four times daily for 20 
weeks was moderately effective in reducing pain 
intensity  regardless of site of application and dose, and 
was well tolerated (83).  
Urtica dioica 
Urtica dioica commonly known as stinging 
nettle is a plant native to northern America, Asia and 
Europe. Extracts of this plant show potent anti-
inflammatory properties through inhibiting the 
proinflammatory transcription factor NF-κB (84). Oral 
administration of this plant decreases the level of CRP 
and can improve inflammatory conditions (85). 
Significant alleviation of pain and stiffness,anti-
inflammatory and analgesic effects were observed in 
patients with OA by using topical nettle leaf in a 
randomized clinical trial (86). Phytalgic is a food 
supplement that contains fish oils, vitamin E, zinc and 
urtica dioica. After 3 months of treatment, phytalgic 
reduced the use of NSAIDs and improved pain, stiffnes 
and function compared to placebo (87). 
Glycine max/Persea americana  
Glycine max commonly known as soybean is a 
plant native to East Asia. Persea Americana commonly 
known as Avocado is a fruit native to Central America. 
Avocado/soybean unsaponifiables (ASU) is believed 
to have anti-inflammatory effects. It can suppress the 
expression of IL-1β, TNF-α and COX-2 genes. 
Moreover, this mixture decreases the production of NO 
and PGE2 in chondrocytes and macrophages (88). 
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ASU also decreases pro-inflammatory cytokines and 
COX-2 expression through the NF-κB signaling 
pathway (89). phytosterols β-sitosterol, campesterol, 
and stigmasterol are major components of ASU which 
are rapidly incorporated into cells. ASU is a complex 
mixture of many compounds including fat-soluble 
vitamins, sterols, triterpene alcohols, and possibly 
furan fatty acids. The identity of the active 
component(s) remains unknown. The primary 
contributors to biological activity particularly in 
chondrocytes are the sterol contents of ASU 
preparations (90). ASU increases the level of TGF-β1 
and TGF-β2 these two play an important role in 
repairing the cartilage of joint (91). Clinically, ASU 
reduces joint stiffness and pain. It also improves the 
function of joint and decreases the usage of NSAIDs. 
Various randomized, double-blind, multicenter trials 
have investigated ASU efficacy and safety during and 
after treatment of patient with symptomatic knee or hip 
OA. Two studies conducted over a 3-month period 
reported that standard treatment with 300 mg/day of 
ASU improved indices of pain, stiffness, and physical 
function (92, 93). A third trial conducted over 6 months 
reported improved functioning similar to placebo, 
measured by the Lequense Functional Index, however, 
ASU had persistent effects after termination of 
treatment (94). In adition,some systematic reviews also 
show that ASU has superior effect compared to 
placebo in controlling symptoms of OA especially in 
patients with OA of the knee (95, 96). 
Herbal medicine, a possible 
option for treating OA 
Diseases affecting the musculoskeletal system 
are a major cause of disability worldwide, especially in 
elder population. OA is the most common 
musculoskeletal disorder that causes significant 
financial burden on health care systems. Elderliness 
and obesity are major risk factors for OA and a 
considerable percent of elder population have clinical 
or radiological signs of OA. This disease is 
accompanied by a number of symptoms with pain 
being the most important one. Joint pain caused by OA 
reduces the patient's quality of life and causes 
remarkable morbidity for patients (97). As of present 
date, there is no effective treatment for curing OA. 
Alleviating the symptoms is the main goal of current 
OA treatment protocols. NSAIDs and opioids are the 
most common effective drugs used for treating OA. 
However, unfortunately these drugs are not very 
effective in OA patients and can only cause small or at 
their best, modest relief of symptoms. Moreover, 
advanced OA often requires joint replacement to 
reduce pain and disability (98). NSAIDs and opioids 
can cause serious and life threatening side effects 
specially in elder population. NSAIDs can cause ulcers 
in gastrointestinal system. Additionally, NSAIDs 
increase the risk of cardiovascular diseases and can 
increase the risk of blood clot formation in arteries. 
NSAIDs can impair the effects of aspirin's platelet 
inhibition and thus increase the risk of mortality in 
patients using aspirin (99). Nephrotoxicity is another 
major side effect of NSAIDs (100). Opioids, especially 
after long term use, cause tolerance and physical 
dependence. They also impair the function of immune 
system and increase the risk of infections. Hormonal 
changes, hyperalgesia, constipation and bladder 
dysfunction are some of the other adverse effects of 
opioids (101). Because of the relatively low effects of 
common drugs used for treating OA and their adverse 
effects that can cause significant morbidity and 
mortality specially for elder patients, researchers are 
looking for safer and more effective therapies for OA. 
Usage of glucosamine and chondroitin sulfate is an 
example of these new therapies. But in a large study, it 
had no superior effect compared to placebo for pain 
and functional improvement (102). Herbal medicine is 
another therapeutic option that researchers around the 
world are trying to use as an adjuvant or 
complementary therapy for OA. Usage of dietary 
supplements and herbal remedies have become 
important research subjects in rheumatology and 
orthopaedics. Herbal medicines contain dozens of 
chemical substances with different effects including 
anti-bacterial, anti-fungal and anti-inflammatory 
effects (103). Herbal medicines are vastly used because 
of their lower price, wide availability and popular 
belief that they have less side effects than chemical 
drugs (104). Herbal remedies have been traditionally 
used for OA treatment. Inflammation and oxidative 
stress can lead to the destruction of joint cartilage and 
thus are important factors in the pathogenesis of OA 
(105). Different herbal medicines can improve the 
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symptoms of OA by different mechanisms of action. 
They can decrease oxidative stress (i.e., NO), prevent 
cartilage degradation by destructive metalloproteinase 
s(e.g., MMP-3, MMP-9), reduce the levels of 
inflammatory cytokines such as TNF-α, IL-1α, IL-6, 
IL-8, and inhibit the NF-κB inflammatory pathway. 
Moreover, they have analgesic and anti-nociceptive 
effects. Although believed to be mostly harmless, 
herbal medicines may in fact cause several side effects. 
Usage of contaminated herbs, interaction with other 
drugs and harmful active substances in some herbs can 
lead to development of side effects including 
nephrotoxicity and potential cardiac problems (106). 
Between all herbal products, capsaicin is one of the 
new herbs recommended by many guidelines to 
manage pain in OA patients (107) but for other herbal 
drugs, including those reviewed in this article, the 
current evidence is sparse and therefore seems to be 
insufficient to reliably judge the efficacy of these 
therapies in OA. The data regarding several herbal 
remedies (e.g. Harpagophytum procumbens), 
however, seem to be sufficiently encouraging to 
warrant large-scale, definitive studies of these 
medicines.  
Conclusion 
The number of elder people is rapidly growing 
around the world. This growth results in an increased 
incidence of age-related diseases such as OA. Common 
drugs used to treat OA, have small to moderate effects 
and considerable side effects specially in older 
patients, leading many patients to use other treatment 
options. Herbal medicine is a popular treatment option 
for many patients. Believed to be "natural", usage of 
herbal medicines is growing worldwide. Although 
there are some evidence for positive effects of herbal 
medicines on OA, more reliable studies and clinical 
trials are needed to prove the definite alleviating role 
of herbal medicines and identify possible side effects 
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